COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,878 Articles (22,568 medRxiv, 8,310 bioRxiv)

Most recent first Previous |  Page 1662: Articles 16611-16620  | Next

Evaluation of serum antibodies against SARS-CoV-2 in healthcare workers who participated in the operation of charter flights for the evacuation of Japanese residents from Hubei Province
Suzuki, T., Hayakawa, K., Ainai, A., Iwata-Yoshikawa, N., Sano, K., Nagata, N., Suzuki, T., Wakimoto, Y., Akiyama, Y., Miyazato, Y., Nakamura, K., Ide, S., Nomoto, H., Nakamoto, T., Ota, M., Moriyama, Y., Sugiki, Y., Saito, S., Morioka, S., Ishikane, M., Kinoshita, N., Kutsuna, S., Ohmagari, N.
10.1101/2021.03.17.21251964 — Posted: 2021-03-20
COVID-19 IN IRAQ, THE RURAL INITIATION (AL-MUTHANNA PROVINCE AS AN EXAMPLE)
Thwiny, H. T., Jaber, S. I., Ateya, H. K., Al-Yasari, A. M., Alsalih, N. J., AL- Saadawe, M. A., Jasim, E. S., Alsaadawi, M. A.
10.1101/2021.03.16.21251969 — Posted: 2021-03-20
Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine reported to EudraVigilance database
Tobaiqy, M., Elkout, H., MacLure, K.
10.1101/2021.03.19.21253980 — Posted: 2021-03-20 Discussion: Onsite
Heterogeneous immunological recovery trajectories revealed in post-acute COVID-19
Su, Y., Yuan, D., Chen, D. G., Wang, K., Choi, J., Dai, C. L., Hong, S., Zhang, R., Xie, J., Li, S., Scherler, K., Pavlovitch-Bedzyk, A.-J., Dong, S., Lausted, C., Ng, R. H., Lee, I., Fallen, S., Kornilov, S. A., Baloni, P., Duvvuri, V. R., Anderson, K. G., Li, J., Yang, F., Rostomily, C., Troisch, P., Smith, B., Zhou, J., Mackay, S., Murry, K., Edmark, R., Jones, L., Zhou, Y., Rowen, L., Liu, R., Chour, W., Berrington, W. R., Wallick, J. A., Algren, H. A., Wrin, T., Petropoulos, C., Wei, W., Price, N. D., Subramanian, N., Hadlock, J., Magis, A. T., Ribas, A., Lanier, L. L., Boyd, S. D., Bluestone, J. A., Hood, L., Gottardo, R., Greenberg, P. D., Davis, M. M., Goldman, J. D., Heath, J. R.
10.1101/2021.03.19.21254004 — Posted: 2021-03-20
Low levels of protective humoral immunity following mild or asymptomatic infection with SARS-CoV-2 in a community-based serological study
McDade, T. W., Sancilio, A., D'Aquila, R. T., Mustanski, B., Vaught, L. A., Reiser, N. L., Velez, M. P., Hsieh, R. R., Ryan, D. T., Saber, R., McNally, E. M., Demonbreun, A. R.
10.1101/2021.03.19.21253982 — Posted: 2021-03-20
Exploring causal relationships between COVID-19 and cardiometabolic disorders: A bi-directional Mendelian randomization study
XIANG, Y., CHAU, C. K.-L., QIU, J., RAO, S., So, H.-C.
10.1101/2021.03.20.21254008 — Posted: 2021-03-20
Alternative splicing of OAS1 alters the risk for severe COVID-19
Huffman, J., Butler-Laporte, G., Khan, A., Drivas, T. G., Peloso, G. M., Nakanishi, T., Verma, A., Kiryluk, K., Richards, J. B., Zeberg, H.
10.1101/2021.03.20.21254005 — Posted: 2021-03-20
Pulmonary Fibrosis after COVID-19 is Associated with Severity of Illness and Blood Leukocyte Telomere Length
McGroder, C. F., Zhang, D., Choudhury, M. A., Salvatore, M. M., D'Souza, B. M., Hoffman, E. A., Wei, Y., Baldwin, M. R., Kim Garcia, C.
10.1101/2021.03.17.21253834 — Posted: 2021-03-20
COVID-19 Neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital
Thakur, K., Miller, E. H., Glendinning, M. D., Al Dalahmah, O., Banu, M., Boehme, A. K., Boubour, A., Bruce, S., Chong, A. M., Claassen, J., Faust, P., Hargus, G., Hickman, R., Jambawalikar, S., Khandji, A., Kim, C., Klein, R. S., Lignelli-Dipple, A., Lin, C.-C., Liu, Y., Miller, M., Moonis, G., Nordvig, A., Overdevest, J., Prust, M., Przedborski, S., Roth, W., Soung, A., Tanji, K., Teich, A., Agalliu, D., Uhlemann, A.-C., Goldman, J. E., Canoll, P.
10.1101/2021.03.16.21253167 — Posted: 2021-03-20
Serological response to COVID-19 vaccination in IBD patients receiving biologics
Wong, S.-Y., Dixon, R., Martinez Pazos, V., ICARUS-IBD, , Gnjatic, S., Colombel, J.-F., Cadwell, K.
10.1101/2021.03.17.21253848 — Posted: 2021-03-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).